Suchergebnisse - "Yokoyama, Keitaro"

PubPharm (139)

1

First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: Pharmacokinetic and Pharmacodynamic Properties

enthalten in: Clinical pharmacokinetics | 2022

von Kazama, J. | Koiwa, F. | Yokoyama, K. | +4

2

Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study

enthalten in: Clinical and experimental nephrology | 2022

von Yokoyama, K. | Hashimoto, T. | Okuda, Y. | +5

3

Safety and efficacy of etelcalcetide, an intravenous calcimimetic, for up to 52 weeks in hemodialysis patients with secondary hyperparathyroidism: results of a post-marketing surveillance in Japan

enthalten in: Clinical and experimental nephrology | 2020

von Yokoyama, K. | Fukagawa, M. | Shigematsu, T. | +5

4

Dysfunctional ABCG2 gene polymorphisms are associated with serum uric acid levels and all-cause mortality in hemodialysis patients

enthalten in: Human cell | 2020

von Nakashima, A. | Ichida, K. | Ohkido, I. | +9

5

Relationship between serum calcium or phosphate levels and mortality stratified by parathyroid hormone level: an analysis from the MBD-5D study

enthalten in: Clinical and experimental nephrology | 2020

von Asada, S. | Yokoyama, K. | Miyakoshi, C. | +8

6

Clinical outcome of incident peritoneal dialysis patients with diabetic kidney disease

enthalten in: Clinical and experimental nephrology | 2018

von Kishida, K. | Maruyama, Y. | Asari, K. | +7

7

Long-term effects of etelcalcetide as intravenous calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism

enthalten in: Clinical and experimental nephrology | 2017

von Shigematsu, T. | Fukagawa, M. | Yokoyama, K. | +4

8

An introduction to CKD-MBD research: restart for the future

enthalten in: Clinical and experimental nephrology | 2017

von Fukagawa, M. | Inaba, M. | Yokoyama, K. | +3

9

A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialysis patients

enthalten in: Nephrology, dialysis, transplantation | 2017

von Fukagawa, M. | Yokoyama, K. | Shigematsu, T. | +5

10

Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open‐label, multicentre, 12‐week phase III study

enthalten in: Nephrology | 2017

von Koiwa, F. | Yokoyama, K. | Fukagawa, M. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]